Akari Therapeutics, Plc
AKTX
$0.34
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.48M | 2.71M | 2.58M | 2.60M | 2.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 349.00K | 447.00K | 627.00K | 92.00K | 396.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 113.00K | 143.00K | 140.00K | 261.00K | 92.00K |
| Total Current Assets | 2.95M | 3.30M | 3.35M | 2.95M | 2.73M |
|
|
|||||
| Total Current Assets | 2.95M | 3.30M | 3.35M | 2.95M | 2.73M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 8.43M | 8.43M | 8.43M | 8.43M | -- |
| Goodwill | 8.43M | 8.43M | 8.43M | 8.43M | -- |
| Total Other Intangibles | 34.00M | 39.18M | 39.18M | 39.18M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 45.38M | 50.91M | 50.96M | 50.56M | 2.73M |
|
|
|||||
| Total Accounts Payable | 10.84M | 11.61M | 13.07M | 12.41M | 4.78M |
| Total Accrued Expenses | 1.62M | 2.47M | 3.49M | 3.14M | 2.61M |
| Short-term Debt | 2.12M | 1.55M | 1.85M | 3.26M | 1.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 984.00K | 1.52M | 2.50M | 1.11M | 1.04M |
| Total Other Current Liabilities | 984.00K | 1.52M | 2.50M | 1.11M | 1.04M |
| Total Current Liabilities | 15.57M | 17.14M | 20.91M | 19.91M | 9.43M |
|
|
|||||
| Total Current Liabilities | 15.57M | 17.14M | 20.91M | 19.91M | 9.43M |
| Long-Term Debt | 100.00K | -- | -- | -- | -- |
| Short-term Debt | 2.12M | 1.55M | 1.85M | 3.26M | 1.00M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.02M | 8.17M | 8.31M | 8.42M | -- |
| Total Liabilities | 22.69M | 25.31M | 29.21M | 28.33M | 9.43M |
|
|
|||||
| Common Stock & APIC | 230.89M | 227.37M | 221.28M | 218.03M | 185.52M |
| Retained Earnings | -259.25M | -252.85M | -250.96M | -247.25M | -243.48M |
| Treasury Stock & Other | 51.05M | 51.09M | 51.42M | 51.46M | 51.27M |
| Total Common Equity | 22.69M | 25.61M | 21.75M | 22.23M | -6.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.69M | 25.61M | 21.75M | 22.23M | -6.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.69M | 25.61M | 21.75M | 22.23M | -6.69M |
|
|
|||||